Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2012

01-11-2012 | Review

The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors

Authors: Bryce B. Reeve, Angela M. Stover, Catherine M. Alfano, Ashley Wilder Smith, Rachel Ballard-Barbash, Leslie Bernstein, Anne McTiernan, Kathy B. Baumgartner, Barbara F. Piper

Published in: Breast Cancer Research and Treatment | Issue 1/2012

Login to get access

Abstract

Brief, valid measures of fatigue, a prevalent and distressing cancer symptom, are needed for use in research. This study’s primary aim was to create a shortened version of the revised Piper Fatigue Scale (PFS-R) based on data from a diverse cohort of breast cancer survivors. A secondary aim was to determine whether the PFS captured multiple distinct aspects of fatigue (a multidimensional model) or a single overall fatigue factor (a unidimensional model). Breast cancer survivors (n = 799; stages in situ through IIIa; ages 29–86 years) were recruited through three SEER registries (New Mexico, Western Washington, and Los Angeles, CA) as part of the Health, Eating, Activity, and Lifestyle (HEAL) study. Fatigue was measured approximately 3 years post-diagnosis using the 22-item PFS-R that has four subscales (Behavior, Affect, Sensory, and Cognition). Confirmatory factor analysis was used to compare unidimensional and multidimensional models. Six criteria were used to make item selections to shorten the PFS-R: scale’s content validity, items’ relationship with fatigue, content redundancy, differential item functioning by race and/or education, scale reliability, and literacy demand. Factor analyses supported the original 4-factor structure. There was also evidence from the bi-factor model for a dominant underlying fatigue factor. Six items tested positive for differential item functioning between African-American and Caucasian survivors. Four additional items either showed poor association, local dependence, or content validity concerns. After removing these 10 items, the reliability of the PFS-12 subscales ranged from 0.87 to 0.89, compared to 0.90–0.94 prior to item removal. The newly developed PFS-12 can be used to assess fatigue in African-American and Caucasian breast cancer survivors and reduces response burden without compromising reliability or validity. This is the first study to determine PFS literacy demand and to compare PFS-R responses in African-Americans and Caucasian breast cancer survivors. Further testing in diverse populations is warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Andrykowski MA, Curran SL, Lightner R (1998) Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21(1):1–18PubMedCrossRef Andrykowski MA, Curran SL, Lightner R (1998) Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21(1):1–18PubMedCrossRef
3.
go back to reference Piper BF, Cella D (2010) Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Cancer Netw 8(8):958–966 Piper BF, Cella D (2010) Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Cancer Netw 8(8):958–966
5.
go back to reference Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743–753PubMed Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743–753PubMed
6.
go back to reference Meeske K, Smith AW, Alfano CM, McGregor BA, McTiernan A, Baumgartner KB, Malone KE, Reeve BB, Ballard-Barbash R, Bernstein L (2007) Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res 16(6):947–960. doi:10.1007/s11136-007-9215-3 PubMedCrossRef Meeske K, Smith AW, Alfano CM, McGregor BA, McTiernan A, Baumgartner KB, Malone KE, Reeve BB, Ballard-Barbash R, Bernstein L (2007) Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res 16(6):947–960. doi:10.​1007/​s11136-007-9215-3 PubMedCrossRef
8.
go back to reference Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMed Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMed
9.
go back to reference Theodosopoulou H, Tzavelas G, Kotrosiou E, Raftopoulos V, Konstaninou E, Anatasiou N (2001) Psychometric properties of the revised Piper Fatigue Scale in Greek women with breast cancer. Icus Nurs Web J 8:1–15. doi:1108-7366 Theodosopoulou H, Tzavelas G, Kotrosiou E, Raftopoulos V, Konstaninou E, Anatasiou N (2001) Psychometric properties of the revised Piper Fatigue Scale in Greek women with breast cancer. Icus Nurs Web J 8:1–15. doi:1108-7366
10.
go back to reference Gledhill JA, Rodary C, Mahe C, Laizet C (2002) French validation of the revised Piper Fatigue Scale. Recherche en soins infirmiers 68:50–65PubMed Gledhill JA, Rodary C, Mahe C, Laizet C (2002) French validation of the revised Piper Fatigue Scale. Recherche en soins infirmiers 68:50–65PubMed
13.
go back to reference Mota DD, Pimenta CA, Piper BF (2009) Fatigue in Brazilian cancer patients, caregivers, and nursing students: a psychometric validation study of the Piper Fatigue Scale-Revised. Support Care Cancer 17(6):645–652. doi:10.1007/s00520-008-0518-x PubMedCrossRef Mota DD, Pimenta CA, Piper BF (2009) Fatigue in Brazilian cancer patients, caregivers, and nursing students: a psychometric validation study of the Piper Fatigue Scale-Revised. Support Care Cancer 17(6):645–652. doi:10.​1007/​s00520-008-0518-x PubMedCrossRef
14.
go back to reference McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. Journal of Clin Oncol 21(10):1961–1966. doi:10.1200/JCO.2003.07.057 CrossRef McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. Journal of Clin Oncol 21(10):1961–1966. doi:10.​1200/​JCO.​2003.​07.​057 CrossRef
15.
go back to reference Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K, Baumgartner KB, Fetherolf J, Reeve BB, Smith AW, Ganz PA, McTiernan A, Barbash RB (2007) Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 106(1):85–95. doi:10.1007/s10549-006-9479-2 PubMedCrossRef Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K, Baumgartner KB, Fetherolf J, Reeve BB, Smith AW, Ganz PA, McTiernan A, Barbash RB (2007) Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 106(1):85–95. doi:10.​1007/​s10549-006-9479-2 PubMedCrossRef
16.
go back to reference Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25(1):51–62PubMed Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25(1):51–62PubMed
17.
go back to reference Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC (1998) Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 25(5):915–920PubMed Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC (1998) Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 25(5):915–920PubMed
18.
go back to reference Wu HS, McSweeney M (2001) Measurement of fatigue in people with cancer. Oncology Nurs Forum 28(9):1371–1384; quiz 1385-1376 Wu HS, McSweeney M (2001) Measurement of fatigue in people with cancer. Oncology Nurs Forum 28(9):1371–1384; quiz 1385-1376
20.
21.
go back to reference West SG, Finch JF, Curran PJ (1995) SEM with nonnormal variables. In: Hoyle RH (ed) Structural equation modeling: concepts issues and applications. Sage Publications, Thousand Oaks, CA West SG, Finch JF, Curran PJ (1995) SEM with nonnormal variables. In: Hoyle RH (ed) Structural equation modeling: concepts issues and applications. Sage Publications, Thousand Oaks, CA
23.
go back to reference Browne MW, Cudeck R (1993) Alternative ways of assessing model fit. In: Bollen KA, Long JS (eds) Testing structural equation models. Sage Publications, Newbury Park, CA Browne MW, Cudeck R (1993) Alternative ways of assessing model fit. In: Bollen KA, Long JS (eds) Testing structural equation models. Sage Publications, Newbury Park, CA
25.
go back to reference Samejima F (1969) Estimation of latent ability using a response pattern of graded scores. Psychometrika 34(4p2):1 Samejima F (1969) Estimation of latent ability using a response pattern of graded scores. Psychometrika 34(4p2):1
26.
go back to reference Samejima F (1997) Graded response model. In: van der Linden WJ, Hambleton RK (eds) Handbook of modern item response theory. Springer, New York, pp 85–100 Samejima F (1997) Graded response model. In: van der Linden WJ, Hambleton RK (eds) Handbook of modern item response theory. Springer, New York, pp 85–100
27.
go back to reference Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, Thissen D, Revicki DA, Weiss DJ, Hambleton RK, Liu H, Gershon R, Reise SP, Lai JS, Cella D, Group PC (2007) Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 45(5 Suppl 1):S22–S31. doi:10.1097/01.mlr.0000250483.85507.04 PubMedCrossRef Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, Thissen D, Revicki DA, Weiss DJ, Hambleton RK, Liu H, Gershon R, Reise SP, Lai JS, Cella D, Group PC (2007) Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 45(5 Suppl 1):S22–S31. doi:10.​1097/​01.​mlr.​0000250483.​85507.​04 PubMedCrossRef
28.
go back to reference Chen WH, Thissen D (1997) Local dependence indexes for item pairs: using item response theory. J Educ Behav Stat 22(3):265–289 Chen WH, Thissen D (1997) Local dependence indexes for item pairs: using item response theory. J Educ Behav Stat 22(3):265–289
29.
go back to reference Nunnally JC, Bernstein IH (1994) Pscyhometric theory, 3rd edn. McGraw-Hill, New York Nunnally JC, Bernstein IH (1994) Pscyhometric theory, 3rd edn. McGraw-Hill, New York
31.
go back to reference Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D, Group PC (2011) Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment 18(3):263–283. doi:10.1177/1073191111411667 PubMedCrossRef Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D, Group PC (2011) Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment 18(3):263–283. doi:10.​1177/​1073191111411667​ PubMedCrossRef
32.
go back to reference Institute of Medicine (2004) Health literacy: a prescription to end confusion. The National Academies Press, Washington, DC Institute of Medicine (2004) Health literacy: a prescription to end confusion. The National Academies Press, Washington, DC
33.
go back to reference Yen WM (1993) Scaling performance assessments—strategies for managing local item dependence. J Educ Meas 30(3):187–213CrossRef Yen WM (1993) Scaling performance assessments—strategies for managing local item dependence. J Educ Meas 30(3):187–213CrossRef
34.
go back to reference Annunziata MA, Muzzatti B, Mella S, Narciso D, Giacalone A, Fratino L, Tirelli U (2010) The revised Piper Fatigue Scale (PFS-R) for Italian cancer patients: a validation study. Tumori 96(2):276–281PubMed Annunziata MA, Muzzatti B, Mella S, Narciso D, Giacalone A, Fratino L, Tirelli U (2010) The revised Piper Fatigue Scale (PFS-R) for Italian cancer patients: a validation study. Tumori 96(2):276–281PubMed
35.
go back to reference Clark PC, Ashford S, Burt R, Aycock DM, Kimble LP (2006) Factor analysis of the revised Piper Fatigue Scale in a caregiver sample. J Nurs Meas 14(2):71–78PubMedCrossRef Clark PC, Ashford S, Burt R, Aycock DM, Kimble LP (2006) Factor analysis of the revised Piper Fatigue Scale in a caregiver sample. J Nurs Meas 14(2):71–78PubMedCrossRef
36.
go back to reference Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, McTiernan A, Bernstein L, Baumgartner KB, Ulrich CM, Ballard-Barbash R (2012) Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J Clin Oncol 30(12):1280–1287. doi:10.1200/JCO.2011.36.4109 PubMedCrossRef Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, McTiernan A, Bernstein L, Baumgartner KB, Ulrich CM, Ballard-Barbash R (2012) Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J Clin Oncol 30(12):1280–1287. doi:10.​1200/​JCO.​2011.​36.​4109 PubMedCrossRef
Metadata
Title
The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors
Authors
Bryce B. Reeve
Angela M. Stover
Catherine M. Alfano
Ashley Wilder Smith
Rachel Ballard-Barbash
Leslie Bernstein
Anne McTiernan
Kathy B. Baumgartner
Barbara F. Piper
Publication date
01-11-2012
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2212-4

Other articles of this Issue 1/2012

Breast Cancer Research and Treatment 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine